medCPU raise $8M for its clinical decision support solution

medCPU

Enterprise clinical decision support solution provider medCPU has closed an $8 million financing round, consisting of $5 million series B-2 equity and $3 million in debt financing. Merck Global Health Innovation Fund and New Richmond Ventures led the equity round, while debt financing was provided by Silicon Valley Bank.

“In the past, the adoption of decision support has been stifled by outdated technologies that do not meet the needs of today’s clinicians,” said Sonia Ben-Yehuda, President and Co-Founder of medCPU. “Unlike older, unreliable technologies that cause alert fatigue among clinicians, our solution delivers highly accurate and reliable decision support to clinicians at the point-of-care in real-time without disrupting their workflow.”

medCPU Advisor is already being used by over 20,000 clinicians and a number of leading healthcare providers.medCPU’s enterprise platform technology, called medCPU Advisor, acquires and processes both structured and unstructured data immediately as it is entered into a clinician’s Electronic Medical Record (EMR) system. The technology then assesses the data against best practice modules to provide the clinician with a holistic view of their patient and to ultimately provide accurate, real-time, reliable prompts at the point-of-care.

medCPU Advisor is already being used by over 20,000 clinicians and a number of leading healthcare providers. It is simple and seamless to deploy as it does not require integration into an EMR system or complex data connectivity to an interface engine.

Running in the background of an EMR system unseen, the system reads and captures data without disrupting a clinician’s workflow and only provides notifications when deviation from best practice care consideration occurs. medCPU offers modules for Obstetrics, Spine, Stroke, CHF, COPD, Value Based Purchasing, DRG’s, ICD-10, VTE Prophylaxis, Population Health, and in partnership with ILÚM Health Solutions (a subsidiary of Merck) is developing modules for Infectious Diseases such as Sepsis, Pneumonia and Urinary Tract Infection that also enable comprehensive Antimicrobial Stewardship.